{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:57Z","timestamp":1791389097123,"version":"4.3.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Pfizer Inc., New York, NY, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s13555-023-00908-0","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T18:02:28Z","timestamp":1679508148000},"page":"935-950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension"],"prefix":"10.1007","volume":"13","author":[{"given":"Jonathan","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Kirsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Adiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Billings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Kerkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"issue":"4","key":"908_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13670-018-0257-x","volume":"7","author":"AK Rzepecki","year":"2018","unstructured":"Rzepecki AK, Blasiak R. Stasis dermatitis: differentiation from other common causes of lower leg inflammation and management strategies. Curr Geriat Rep. 2018;7(4):222\u20137.","journal-title":"Curr Geriat Rep"},{"issue":"3","key":"908_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40257-016-0250-0","volume":"18","author":"S Sundaresan","year":"2017","unstructured":"Sundaresan S, Migden MR, Silapunt S. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol. 2017;18(3):383\u201390.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"908_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaad.2009.04.025","volume":"61","author":"J Weaver","year":"2009","unstructured":"Weaver J, Billings SD. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario. J Am Acad Dermatol. 2009;61(6):1028\u201332.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"908_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/153100350501700406","volume":"17","author":"JV White","year":"2005","unstructured":"White JV, Ryjewski C. Chronic venous insufficiency. Persp Vasc Surg Endovasc Ther. 2005;17(4):319\u201327.","journal-title":"Persp Vasc Surg Endovasc Ther"},{"issue":"2","key":"908_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ije\/15.2.210","volume":"15","author":"FHA Maffei","year":"1986","unstructured":"Maffei FHA, Magaldi C, Pinho S, et al. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidem. 1986;15(2):210\u20137.","journal-title":"Int J Epidem"},{"issue":"6","key":"908_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-4632.2005.02607.x","volume":"45","author":"B Yalcin","year":"2006","unstructured":"Yalcin B, Tamer E, Toy GG, Oztas P, Hayran M, Alli N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006;45(6):672\u20136.","journal-title":"Int J Dermatol"},{"key":"908_CR7","unstructured":"American Academy of Dermatology. Eczema types: stasis dermatitis signs and symptoms. https:\/\/www.aad.org\/public\/diseases\/eczema\/types\/stasis-dermatitis\/symptoms. Accessed 1 July 2022."},{"issue":"6","key":"908_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00439-010-0812-9","volume":"127","author":"A Fiebig","year":"2010","unstructured":"Fiebig A, Krusche P, Wolf A, et al. Heritability of chronic venous disease. Human Gen. 2010;127(6):669\u201374.","journal-title":"Human Gen"},{"key":"908_CR9","doi-asserted-by":"crossref","unstructured":"Silverberg JI, Hou A, Warshaw EM, et al. Prevalence and trend of allergen sensitization in patients with a diagnosis of stasis dermatitis referred for patch testing, North American contact dermatitis group data, 2001\u20132016. Arch Derm Res. 2022;314(9):857\u201367.","DOI":"10.1007\/s00403-021-02295-y"},{"issue":"2","key":"908_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1524-475X.2009.00468.x","volume":"17","author":"MI Shiman","year":"2009","unstructured":"Shiman MI, Pieper B, Templin TN, Birk TJ, Patel AR, Kirsner RS. Venous ulcers: a reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion upon gait and calf muscle function. Wound Repair Regen. 2009;17(2):147\u201352.","journal-title":"Wound Repair Regen"},{"issue":"10","key":"908_CR11","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/archderm.143.10.1305","volume":"143","author":"B Pieper","year":"2007","unstructured":"Pieper B, Kirsner RS, Templin TN, Birk TJ. Injection drug use: an understudied cause of venous disease. Arch Dermatol. 2007;143(10):1305\u20139.","journal-title":"Arch Dermatol"},{"issue":"1","key":"908_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0733-8635(03)00113-X","volume":"22","author":"A Theodosat","year":"2004","unstructured":"Theodosat A. Skin diseases of the lower extremities in the elderly. Dermatol Clin. 2004;22(1):13\u201321.","journal-title":"Dermatol Clin"},{"issue":"7","key":"908_CR13","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1253\/circj.CJ-13-1599","volume":"78","author":"K Suehiro","year":"2014","unstructured":"Suehiro K, Morikage N, Murakami M, et al. A study of leg edema in immobile patients. Circ J. 2014;78(7):1733\u20139.","journal-title":"Circ J"},{"issue":"5","key":"908_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.12968\/bjcn.2009.14.5.42076","volume":"14","author":"L Nazarko","year":"2009","unstructured":"Nazarko L. Diagnosis and treatment of venous eczema. Br J Community Nurs. 2009;14(5):188\u201394.","journal-title":"Br J Community Nurs"},{"issue":"1","key":"908_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10010029","volume":"10","author":"JD Raffetto","year":"2020","unstructured":"Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. Why venous leg ulcers have difficulty healing: overview on pathophysiology, clinical consequences, and treatment. J Clin Med. 2020;10(1):1\u201334.","journal-title":"J Clin Med"},{"issue":"5","key":"908_CR16","first-page":"239","volume":"86","author":"B Palmer","year":"2010","unstructured":"Palmer B, Xia Y, Cho S, Lewis FS. Acroangiodermatitis secondary to chronic venous insufficiency. Cutis. 2010;86(5):239\u201340.","journal-title":"Cutis"},{"issue":"5","key":"908_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.avsg.2007.07.002","volume":"21","author":"GS Barron","year":"2007","unstructured":"Barron GS, Jacob SE, Kirsner RS. Dermatologic complications of chronic venous disease: medical management and beyond. Ann Vasc Surg. 2007;21(5):652\u201362.","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"908_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1529-8019.2010.01338.x","volume":"23","author":"M Miteva","year":"2010","unstructured":"Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010;23(4):375\u201388.","journal-title":"Dermatol Ther"},{"issue":"4","key":"908_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0190-9622(93)70085-8","volume":"28","author":"RS Kirsner","year":"1993","unstructured":"Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993;28(4):623\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"908_CR20","first-page":"CD000265","volume":"2","author":"N Cullum","year":"2001","unstructured":"Cullum N, Nelson E, Fletcher A, Sheldon T. Compression for venous leg ulcers. Cochr Datab Syst Rev. 2001;2:CD000265.","journal-title":"Cochr Datab Syst Rev"},{"issue":"3","key":"908_CR21","first-page":"231","volume":"8","author":"O Al Shammeri","year":"2014","unstructured":"Al Shammeri O, AlHamdan N, Al-Hothaly B, Midhet F, Hussain M, Al-Mohaimeed A. Chronic venous insufficiency: prevalence and effect of compression stockings. Int J Health Sci. 2014;8(3):231\u20136.","journal-title":"Int J Health Sci"},{"issue":"10","key":"908_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/0268355515608992","volume":"31","author":"K Suehiro","year":"2016","unstructured":"Suehiro K, Morikage N, Yamashita O, et al. Adherence to and efficacy of different compression methods for treating chronic venous insufficiency in the elderly. Phlebol. 2016;31(10):723\u20138.","journal-title":"Phlebol"},{"issue":"6","key":"908_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.avsg.2007.07.014","volume":"21","author":"S Raju","year":"2007","unstructured":"Raju S, Hollis K, Neglen P. Use of compression stockings in chronic venous disease: patient compliance and efficacy. Ann Vasc Surg. 2007;21(6):790\u20135.","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"908_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejvs.2014.11.005","volume":"49","author":"K Sippel","year":"2015","unstructured":"Sippel K, Seifert B, Hafner J. Donning devices (foot slips and frames) enable elderly people with severe chronic venous insufficiency to put on compression stockings. Eur J Vasc Endovasc Surg. 2015;49(2):221\u20139.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"908_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase\u00a04 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494\u2013503.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"908_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","volume":"71","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116\u201332.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"908_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/MJT.0b013e31818a975c","volume":"16","author":"D Pariser","year":"2009","unstructured":"Pariser D. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. Am J Therap. 2009;16(3):264\u201373.","journal-title":"Am J Therap"},{"issue":"1","key":"908_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","volume":"54","author":"UR Hengge","year":"2006","unstructured":"Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"908_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1024\/0301-1526.33.4.260","volume":"33","author":"J Dissemond","year":"2004","unstructured":"Dissemond J, Knab J, Lehnen M, Franckson T, Goos M. Successful treatment of stasis dermatitis with topical tacrolimus. Vasa. 2004;33(4):260\u20132.","journal-title":"Vasa"},{"issue":"2","key":"908_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jaad.2016.02.1228","volume":"75","author":"JA Broeders","year":"2016","unstructured":"Broeders JA, Ali UA, Fischer G. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: a 15-year experience. J Am Acad Dermatol. 2016;75(2):410\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"908_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.5114\/ada.2019.91425","volume":"36","author":"N Ab\u0119d\u017a","year":"2019","unstructured":"Ab\u0119d\u017a N, Pawliczak R. Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials. Postepy Dermatol Alergol. 2019;36(6):752\u20139.","journal-title":"Postepy Dermatol Alergol"},{"issue":"2","key":"908_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2165\/11597780-000000000-00000","volume":"13","author":"HC Frankel","year":"2012","unstructured":"Frankel HC, Qureshi AA. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Am J Clin Dermatol. 2012;13(2):113\u201323.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"908_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1067\/mva.2002.121128","volume":"35","author":"HB McDaniel","year":"2002","unstructured":"McDaniel HB, Marston WA, Farber MA, et al. Recurrence of chronic venous ulcers on the basis of clinical, etiologic, anatomic, and pathophysiologic criteria and air plethysmography. J Vasc Surg. 2002;35(4):723\u20138.","journal-title":"J Vasc Surg"},{"issue":"1","key":"908_CR34","first-page":"19","volume":"20","author":"B Klein","year":"2022","unstructured":"Klein B, Treudler R, Simon JC. JAK-inhibitors in dermatology - small molecules, big impact? Overview of the mechanism of action, previous study results and potential adverse effects. J Dtsch Dermatol Ges. 2022;20(1):19\u201324.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"908_CR35","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/bjd.18469","volume":"182","author":"M Worm","year":"2020","unstructured":"Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TS. Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study. Br J Dermatol. 2020;182(5):1103\u201310.","journal-title":"Br J Dermatol"},{"key":"908_CR36","doi-asserted-by":"crossref","unstructured":"Sawangjit R, Dilokthornsakul P, Lloyd-Lavery A, Lai NM, Dellavalle R, Chaiyakunapruk N. Systemic treatments for eczema: a network meta-analysis. Cochrane Datab Syst Rev. 2020;9(9):CD013206.","DOI":"10.1002\/14651858.CD013206.pub2"},{"issue":"3","key":"908_CR37","first-page":"134","volume":"11","author":"CT Sung","year":"2019","unstructured":"Sung CT, Taguines PR, Jacob SE. Stasis dermatitis. J Derm Nurs Assoc. 2019;11(3):134\u20136.","journal-title":"J Derm Nurs Assoc"},{"issue":"3","key":"908_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jaad.2018.10.034","volume":"80","author":"S Nedorost","year":"2019","unstructured":"Nedorost S, White S, Rowland DY, et al. Development and implementation of an order set to improve value of care for patients with severe stasis dermatitis. J Am Acad Dermatol. 2019;80(3):815\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"908_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3904\/kjim.2018.230","volume":"34","author":"YJ Youn","year":"2019","unstructured":"Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Kor J Intern Med. 2019;34(2):269\u201383.","journal-title":"Kor J Intern Med"},{"issue":"5","key":"908_CR40","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJMra055289","volume":"355","author":"JJ Bergan","year":"2006","unstructured":"Bergan JJ, Schmid-Sch\u00f6nbein GW, Smith PDC, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355(5):488\u201398.","journal-title":"N Engl J Med"},{"issue":"5","key":"908_CR41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejvs.2004.05.012","volume":"28","author":"S Takase","year":"2004","unstructured":"Takase S, Pascarella L, Lerond L, Bergan JJ, Schmid-Schonbein GW. Venous hypertension, inflammation and valve remodeling. Eur J Vasc Endovasc Surg. 2004;28(5):484\u201393.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"908_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1078-5884(96)80051-7","volume":"11","author":"SP Payne","year":"1996","unstructured":"Payne SP, London NJ, Newland CJ, Thrush AJ, Barrie WW, Bell PR. Ambulatory venous pressure: correlation with skin condition and role in identifying surgically correctible disease. Eur J Vasc Endovasc Surg. 1996;11(2):195\u2013200.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"8","key":"908_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1258\/phleb.2010.010043","volume":"26","author":"K Sippel","year":"2011","unstructured":"Sippel K, Mayer D, Ballmer B, et al. Evidence that venous hypertension causes stasis dermatitis. Phlebol. 2011;26(8):361\u20135.","journal-title":"Phlebol"},{"issue":"4","key":"908_CR44","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jid.2019.09.012","volume":"140","author":"T Hashimoto","year":"2020","unstructured":"Hashimoto T, Kursewicz CD, Fayne RA, et al. Mechanisms of itch in stasis dermatitis: significant role of IL-31 from macrophages. J Invest Dermatol. 2020;140(4):850\u20139.","journal-title":"J Invest Dermatol"},{"issue":"6638","key":"908_CR45","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/bmj.296.6638.1693","volume":"296","author":"PR Thomas","year":"1988","unstructured":"Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J. 1988;296(6638):1693\u20135.","journal-title":"Br Med J"},{"issue":"4","key":"908_CR46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0741-5214(93)90109-Y","volume":"17","author":"L Wilkinson","year":"1993","unstructured":"Wilkinson L, Bunker C, Edwards J, Scurr J, Smith PC. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vascul Surg. 1993;17(4):669\u201375.","journal-title":"J Vascul Surg"},{"issue":"4","key":"908_CR47","first-page":"311","volume":"5","author":"C Moyses","year":"1987","unstructured":"Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp. 1987;5(4):311\u201320.","journal-title":"Int J Microcirc Clin Exp"},{"issue":"6","key":"908_CR48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ejvs.2010.08.015","volume":"40","author":"A Caggiati","year":"2010","unstructured":"Caggiati A, Rosi C, Casini A, et al. Skin iron deposition characterises lipodermatosclerosis and leg ulcer. Eur J Vasc Endovasc Surg. 2010;40(6):777\u201382.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"908_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/000155599750011651","volume":"79","author":"M Peschen","year":"1999","unstructured":"Peschen M, Lahaye T, Hennig B, Weyl A, Simon JC, Vanscheidt W. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Dermato-Venereol. 1999;79(1):27\u201332.","journal-title":"Acta Dermato-Venereol"},{"issue":"3","key":"908_CR50","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0190-9622(96)90432-6","volume":"34","author":"A Weyl","year":"1996","unstructured":"Weyl A, Vanscheidt W, Weiss J, Peschen M, Schoepf E, Simon J. Expression of the adhesion molecules ICAM-1, VCAM-1, and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers. J Am Acad Dermatol. 1996;34(3):418\u201323.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"908_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-4362.2003.01709.x","volume":"42","author":"C Kaur","year":"2003","unstructured":"Kaur C, Sarkar R, Kanwar AJ, Attri AK, Dabra AK, Kochhar S. An open trial of calcium dobesilate in patients with venous ulcers and stasis dermatitis. Int J Dermatol. 2003;42(2):147\u201352.","journal-title":"Int J Dermatol"},{"issue":"3","key":"908_CR52","first-page":"287","volume":"14","author":"A Kucukguven","year":"2013","unstructured":"Kucukguven A, Khalil AR. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targ. 2013;14(3):287\u2013324.","journal-title":"Curr Drug Targ"},{"issue":"5","key":"908_CR53","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1067\/mva.2001.119503","volume":"34","author":"S Saito","year":"2001","unstructured":"Saito S, Trovato MJ, You R, et al. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg. 2001;34(5):930\u20138.","journal-title":"J Vasc Surg"},{"issue":"3","key":"908_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0923-1811(00)00128-6","volume":"25","author":"Y Herouy","year":"2001","unstructured":"Herouy Y, Mellios P, Bandemir E, et al. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci. 2001;25(3):198\u2013205.","journal-title":"J Dermatol Sci"},{"issue":"6","key":"908_CR55","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1046\/j.1523-1747.2001.01345.x","volume":"116","author":"J Wenk","year":"2001","unstructured":"Wenk J, Foitzik A, Achterberg V, et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol. 2001;116(6):833\u20139.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"908_CR56","first-page":"1","volume":"1048","author":"H Li","year":"2018","unstructured":"Li H, Zuo J, Tang W. Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front Pharmacol. 2018;1048(9):1\u201321.","journal-title":"Front Pharmacol"},{"issue":"3","key":"908_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms23031209","volume":"23","author":"MA Schick","year":"2022","unstructured":"Schick MA, Schlegel N. Clinical implication of phosphodiesterase-4-inhibition. Int J Mol Sci. 2022;23(3):1\u201319.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"908_CR58","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.cellsig.2015.12.001","volume":"28","author":"SN Rampersad","year":"2016","unstructured":"Rampersad SN, Wudwud A, Hubert F, Maurice DH. Adaptive phenotypic modulation of human arterial endothelial cells to fluid shear stress-encoded signals: modulation by phosphodiesterase\u00a04D-VE-cadherin signalling. Cell Signal. 2016;28(7):741\u20138.","journal-title":"Cell Signal"},{"issue":"5","key":"908_CR59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/CIRCRESAHA.122.321365","volume":"131","author":"Q Wan","year":"2022","unstructured":"Wan Q, Xu C, Zhu L, et al. Targeting PDE4B (phosphodiesterase-4 subtype B) for cardioprotection in acute myocardial infarction via neutrophils and microcirculation. Circul Res. 2022;131(5):442\u201355.","journal-title":"Circul Res"},{"issue":"2","key":"908_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40257-020-00510-6","volume":"21","author":"J Schlessinger","year":"2020","unstructured":"Schlessinger J, Shepard JS, Gower R, et al. Safety, effectiveness, and pharmacokinetics of crisaborole in infants aged 3 to< 24 months with mild-to-moderate atopic dermatitis: a phase IV open-label study (CrisADe CARE 1). Am J Clin Dermatol. 2020;21(2):275\u201384.","journal-title":"Am J Clin Dermatol"},{"key":"908_CR61","unstructured":"ClinicalTrials.gov. Study evaluating efficacy and safety of crisaborole in adults with stasis dermatitis. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04091087. Accessed 26 Sep 2022."},{"issue":"4","key":"908_CR62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2340\/00015555-1968","volume":"95","author":"R Valdes-Rodriguez","year":"2015","unstructured":"Valdes-Rodriguez R, Mollanazar NK, Gonz\u00e1lez-Muro J, et al. Itch prevalence and characteristics in a Hispanic geriatric population: a comprehensive study using a standardized itch questionnaire. Acta Dermato-Venereol. 2015;95(4):417\u201321.","journal-title":"Acta Dermato-Venereol"},{"issue":"7","key":"908_CR63","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2340\/00015555-2417","volume":"96","author":"LA Nattkemper","year":"2016","unstructured":"Nattkemper LA, Martinez-Escala ME, Gelman AB, et al. Cutaneous T-cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin. Acta Derm Venereol. 2016;96(7):894\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"908_CR64","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","volume":"138","author":"LA Nattkemper","year":"2018","unstructured":"Nattkemper LA, Tey HL, Valdes-Rodriguez R, et al. The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J Invest Dermatol. 2018;138(6):1311\u20137.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"908_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","volume":"117","author":"E Sonkoly","year":"2006","unstructured":"Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T\u00a0cells and pruritus in atopic skin inflammation. J Allerg Clin Immunol. 2006;117(2):411\u20137.","journal-title":"J Allerg Clin Immunol"},{"issue":"9","key":"908_CR66","doi-asserted-by":"publisher","first-page":"1906:1","DOI":"10.3390\/jcm10091906","volume":"10","author":"M Furue","year":"2021","unstructured":"Furue M, Furue M. Interleukin-31 and pruritic skin. J Clin Med. 2021;10(9):1906:1-1911.","journal-title":"J Clin Med"},{"key":"908_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1177271920940712","volume":"15","author":"K Salao","year":"2020","unstructured":"Salao K, Sawanyawisuth K, Winaikosol K, Choonhakarn C, Chaowattanapanit S. Interleukin-31 and chronic pruritus of unknown origin. Biomark Insight. 2020;15:1\u20134.","journal-title":"Biomark Insight"},{"issue":"3","key":"908_CR68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1067\/mjd.2001.111633","volume":"44","author":"IC Valencia","year":"2001","unstructured":"Valencia IC, Falabella A, Kirsner RS, Eaglstein WH. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol. 2001;44(3):401\u201321.","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00908-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00908-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00908-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T18:14:32Z","timestamp":1680113672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00908-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00908-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}